Cargando…

(166)Holmium–(99)(m)Technetium dual-isotope imaging: scatter compensation and automatic healthy-liver segmentation for (166)Holmium radioembolization dosimetry

BACKGROUND: Partition modeling allows personalized activity calculation for holmium-166 ((166)Ho) radioembolization. However, it requires the definition of tumor and non-tumorous liver, by segmentation and registration of a separately acquired CT, which is time-consuming and prone to error. A protoc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stella, Martina, Braat, Arthur J. A. T., Lam, Marnix G. E. H., de Jong, Hugo W. A. M., van Rooij, Rob
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9023629/ https://www.ncbi.nlm.nih.gov/pubmed/35445948 http://dx.doi.org/10.1186/s40658-022-00459-x

Ejemplares similares

Automatic healthy liver segmentation for holmium-166 radioembolization dosimetry
por: Stella, Martina, et al.
Publicado: (2023)

Holmium-166 Radioembolization: Current Status and Future Prospective
por: Stella, Martina, et al.
Publicado: (2022)

Gamma camera characterization at high holmium-166 activity in liver radioembolization
por: Stella, Martina, et al.
Publicado: (2021)

Quality of life in patients with liver tumors treated with holmium-166 radioembolization
por: van Roekel, Caren, et al.
Publicado: (2019)

Accuracy of SPECT/CT‐based lung dose calculation for Holmium‐166 hepatic radioembolization before OSEM convergence
por: van Nierop, Bastiaan J., et al.
Publicado: (2018)

Simultaneous (166)Ho/(99m)Tc dual-isotope SPECT with Monte Carlo-based downscatter correction for automatic liver dosimetry in radioembolization
por: van Rooij, R., et al.
Publicado: (2020)

Holmium-166 Transarterial Radioembolization for the Treatment of Intrahepatic Cholangiocarcinoma: A Case Series
por: Vermeulen, Sim, et al.
Publicado: (2023)

Holmium-166 radioembolization for the treatment of patients with liver metastases: design of the phase I HEPAR trial
por: Smits, Maarten LJ, et al.
Publicado: (2010)

Use of an anti-reflux catheter to improve tumor targeting for holmium-166 radioembolization—a prospective, within-patient randomized study
por: van Roekel, Caren, et al.
Publicado: (2020)

Dose finding study for unilobar radioembolization using holmium-166 microspheres to improve resectability in patients with HCC: the RALLY protocol
por: Andel, Daan, et al.
Publicado: (2023)

The various therapeutic applications of the medical isotope holmium-166: a narrative review
por: Klaassen, Nienke J. M., et al.
Publicado: (2019)

Inflammatory markers and long term hematotoxicity of holmium-166-radioembolization in liver-dominant metastatic neuroendocrine tumors after initial peptide receptor radionuclide therapy
por: Ebbers, Sander C., et al.
Publicado: (2022)

Safety analysis of holmium-166 microsphere scout dose imaging during radioembolisation work-up: A cohort study
por: Braat, Arthur J. A. T., et al.
Publicado: (2017)

Surefire infusion system versus standard microcatheter use during holmium-166 radioembolization: study protocol for a randomized controlled trial
por: van den Hoven, Andor F., et al.
Publicado: (2016)

Clinical Results of Transarterial Radioembolization (TARE) with Holmium-166 Microspheres in the Multidisciplinary Oncologic Treatment of Patients with Primary and Secondary Liver Cancer
por: Drescher, Robert, et al.
Publicado: (2023)

The superior predictive value of (166)Ho-scout compared with (99m)Tc-macroaggregated albumin prior to (166)Ho-microspheres radioembolization in patients with liver metastases
por: Smits, Maarten L. J., et al.
Publicado: (2019)

Therapeutic Effects of Holmium-166 Chitosan Complex in Rat Brain Tumor Model
por: Huh, Ryoong, et al.
Publicado: (2005)

Radioembolization With Holmium-166 Polylactic Acid Microspheres: Distribution of Residual Activity in the Delivery Set and Outflow Dynamics During Planning and Treatment Procedures
por: Drescher, Robert, et al.
Publicado: (2021)

Radioembolization Planning With Dual-Isotope Acquisition of (166)Ho-Labeled Microparticles and (99m)Tc-Mebrofenin
por: Czibor, Sándor, et al.
Publicado: (2023)

Intratumoral injection of holmium-166 microspheres as neoadjuvant therapy of soft tissue sarcomas in dogs
por: Morsink, Nino Chiron, et al.
Publicado: (2022)

Therapeutic efficacy of (166)Holmium siloxane in microbrachytherapy of induced glioblastoma in minipig tumor model
por: Khoshnevis, Mehrdad, et al.
Publicado: (2022)

Transarterial Radioembolization Planning and Treatment with Microspheres Containing Holmium-166: Determination of Renal and Intestinal Radionuclide Elimination, Effective Half-Life, and Regulatory Aspects
por: Kühnel, Christian, et al.
Publicado: (2022)

MRI-based biodistribution assessment of holmium-166 poly(L-lactic acid) microspheres after radioembolisation
por: van de Maat, Gerrit H., et al.
Publicado: (2012)

Intraprocedural MRI-based dosimetry during transarterial radioembolization of liver tumours with holmium-166 microspheres (EMERITUS-1): a phase I trial towards adaptive, image-controlled treatment delivery
por: Roosen, Joey, et al.
Publicado: (2022)

Quantitative (166)Ho-microspheres SPECT derived from a dual-isotope acquisition with (99m)Tc-colloid is clinically feasible
por: Stella, M., et al.
Publicado: (2020)

Effects of Intraluminal Irradiation with Holmium-166 for TIPS Stenosis: Experimental Study in a Swine Model
por: Park, Ji Seon, et al.
Publicado: (2007)

Percutaneous Sclerotherapy of Renal Cysts with a Beta-Emitting Radionuclide, Holmium-166-chitosan Complex
por: Kim, Joo Hee, et al.
Publicado: (2004)

Development of an MRI-Guided Approach to Selective Internal Radiation Therapy Using Holmium-166 Microspheres
por: Roosen, Joey, et al.
Publicado: (2021)

Case Report: Radioactive Holmium-166 Microspheres for the Intratumoral Treatment of a Canine Pituitary Tumor
por: Morsink, Nino Chiron, et al.
Publicado: (2021)

Study Protocol: Adjuvant Holmium-166 Radioembolization After Radiofrequency Ablation in Early-Stage Hepatocellular Carcinoma Patients—A Dose-Finding Study (HORA EST HCC Trial)
por: Hendriks, Pim, et al.
Publicado: (2022)

Intratumoral Administration of Holmium-166 Acetylacetonate Microspheres: Antitumor Efficacy and Feasibility of Multimodality Imaging in Renal Cancer
por: Bult, Wouter, et al.
Publicado: (2013)

Intracavitary Radiation Therapy for Recurrent Cystic Brain Tumors with Holmium-166-Chico : A Pilot Study
por: Ha, Eun Jin, et al.
Publicado: (2013)

Intratumoral injection of radioactive holmium-166 microspheres in recurrent head and neck squamous cell carcinoma: preliminary results of first use
por: Bakker, Robbert C., et al.
Publicado: (2018)

A Pilot Study of Trans-Arterial Injection of (166)Holmium-Chitosan Complex for Treatment of Small Hepatocellular Carcinoma
por: Cho, Byoung Chul, et al.
Publicado: (2005)

Clinical effects of transcatheter hepatic arterial embolization with holmium-166 poly(l-lactic acid) microspheres in healthy pigs
por: Vente, M. A. D., et al.
Publicado: (2008)

Fast technetium‐99m liver SPECT for evaluation of the pretreatment procedure for radioembolization dosimetry
por: van der Velden, Sandra, et al.
Publicado: (2018)

Holmium-166 poly(L-lactic acid) microsphere radioembolisation of the liver: technical aspects studied in a large animal model
por: Vente, M. A. D., et al.
Publicado: (2009)

Development of (166)Holmium-1,2 Propylene Di-amino Tetra (Methy1enephosphonicacid) as a Possible Bone Palliation Agent
por: Zolghadri, Samaneh, et al.
Publicado: (2014)

Retraction: Development of 166 Holmium-1,2 Propylene Di-amino Tetra (Methy1enephosphonicacid) as a Possible Bone Palliation Agent
Publicado: (2016)

Personalized predictive lung dosimetry by technetium-99m macroaggregated albumin SPECT/CT for yttrium-90 radioembolization
por: Kao, Yung Hsiang, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_iv6bon1oeej8c8s2f3f1bvpa2o